BusinessNetworkNewsWire Announces Publication featuring Advances in Cannabinoid Products and Therapies for Pain ManagementBy Nasdaq OMXDec 6, 2017, 1:30 PM UTC
BusinessBeyondSpring’s Lead Asset, Plinabulin, Recognized as 2017 National Science and Technology Major Project in ChinaBy Nasdaq OMXDec 4, 2017, 12:00 PM UTC
BusinessBeyondSpring Initiates Global Phase 2/3 Trial with Plinabulin in China for the Prevention of Chemotherapy-Induced Neutropenia to Demonstrate SuperiorityBy Nasdaq OMXNov 30, 2017, 2:58 PM UTC
BusinessBiopharmaceutical Contract Manufacturing Market to hit US$ 15,467.8 Mn by 2027 - Future Market InsightsBy Nasdaq OMXNov 28, 2017, 10:32 AM UTC
BusinessStreetwise Reports Examines Promising 'Hot' Alzheimer's Market for Biotech with 'Novel' Drug CandidateBy Nasdaq OMXNov 23, 2017, 1:45 PM UTC
BusinessAkers Biosciences’ UK Distributor Secures New Channel for Rapid Alcohol BreathalyzerBy Nasdaq OMXNov 14, 2017, 12:00 PM UTC
BusinessSarepta Therapeutics Prices $475 Million of Convertible Senior Notes Due 2024By Nasdaq OMXNov 8, 2017, 11:45 PM UTC
